Cabaletta Bio, Inc. · NASDAQ:CABA
Cabaletta Bio, Inc. shareholders
As of Jun 30, 2026, 132 institutions reported holding Cabaletta Bio, Inc., 93.6% of its shares. Largest: T. Rowe Price, Jennison Associates LLC and Bain Capital Life Sciences Investors, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Cabaletta Bio, Inc. | Change | Filed |
|---|---|---|---|---|
| T. Rowe Price | 23.3M | 13.7% | +11.8M | Aug 14, 2026 |
| Jennison Associates LLC | 20M | 11.8% | +11.1M | Aug 3, 2026 |
| Bain Capital Life Sciences Investors, LLC | 17.2M | 10.2% | +7.56M | Aug 14, 2026 |
| BlackRock | 10.8M | 6.3% | +8.38M | Aug 7, 2026 |
| Vanguard | 9.8M | 5.8% | +5.15M | Aug 13, 2026 |
| Adage Capital Partners Gp, L.L.C. | 9.17M | 5.4% | +345K | Aug 14, 2026 |
| State Street | 7.84M | 4.6% | +7.37M | Aug 7, 2026 |
| Cormorant Asset Management, LP | 5M | 2.9% | −500K | Aug 14, 2026 |
| Woodline Partners LP | 4.2M | 2.5% | +2.95M | Aug 14, 2026 |
| Norges Bank | 4.11M | 2.4% | first report | Aug 12, 2026 |